Twitter

Tuesday, May 31, 2011



Please Give us Your Valued Feed Back to Serve you Better
Edition#6, 1st june 2011                                                                                                    For Browser View:   Click Here

Featured Article

The U.S. Food and Drug Administration today approved Dificid (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD).

      Clostridium difficile (C. difficile) is a bacterium that can cause diarrhea and lead to colitis, other serious intestinal conditions, and death in severe cases. C. difficile bacteria are found in the stool of an infected person, and others can become infected if they touch items or surfaces contaminated with the bacteria or spores and then touch their mouths.

        The safety and efficacy of Dificid were demonstrated in two trials that included 564 patients with CDAD that compared Dificid with vancomycin, a common antibiotic used to treat CDAD. The clinical response was similar in the Dificid group compared with the vancomycin group in both studies. In some patients with CDAD, symptoms can return. In the Dificid trials, a greater number of patients treated with Dificid had a sustained cure three weeks after treatment ended versus those patients treated with vancomycin. 

Source :- Click here




Novartis - Technology for Health Award Winner

      Novartis wins the "Technology for Health" category at the GBC Business Action on Health Awards. Novartis' SMS for Life program, a partnership with Vodafone, IBM, Google, the Tanzanian Ministry of Health and Roll Back Malaria, uses SMS, mobile phone and electronic mapping technology to track weekly stock levels of anti-malarial medicines in remote rural communities..


ICON Central Laboratories launches Cytometry Services

      The Central Laboratories arm of ICON, the global provider of outsourced development services based in Ireland, has launched a global Cytometry Services offering through its facilities in New York (US), Dublin (Ireland), Bangalore (India) and Singapore.




Two more product approvals in Russia for India’s Claris

      Claris Iifesciences Limited (Claris), one of the largest sterile injectables pharmaceutical companies in India, on Thursday announced that it has received approval from Ministry of I lealth (Mo! 1), to market two more antiinfectives viz Fluconazole IV 100 ml. and I.evofloxacin IV 100 ml.



Intestinal cells activate defence against salmonella bug

      Salmonella infection begins with bugs entering the epithelial (outer) cells of the intestine. Then special cell organelles (specialised subunits within a cell), encircle the invaders and become absorbed in other organelles which have special digestive enzymes to break down the bacteria into their constituent parts.





Venus Remedies bags EU patent for once-a-day painkiller 

          Venus Remedies Limited, a leading research based global pharmaceutical company, has been granted another patent by European Patent Office (EPO) for its research drug ACHNIL, a once-a-day painkiller injection.


Ramdev's Patanjali Yoga Center, featured on 

       
Food and Drug Administration (FDA) Department of Yogguru Ramdev Aynder (West) at Patanjali Yoga Shop raided. Department of Ayurvedic medicine there and seized the powder samples for testing.



India, Italy to set up joint working group to strengthen ties in pharma sector

       India and Italy will set up a Joint Working Group (JWG) to boost the bilateral relationship in the pharmaceutical sector as both countries have identified pharma as a key area for collaboration in the coming times.




Income tax raids on pharma company fetch Rs 55 crore

      Undisclosed income worth Rs 55 crore (Rs 550 million) was found during income tax raids at the premises of the Ind-Swift group, a leading pharmaceutical company in northern India




Chennai Super Kings beat Royal Challengers Bangalore to win IPL 4

          CHENNAI: The Super Kings are the emperors of India.
In the battlefield called Chepauk, Dhoni's army ambushed the Royal Challengers to defend the citadel they had clinched in Mumbai last year. The Chennai mean machine started working from Ball One with M Vijay (95 off 52 balls) and Mike Hussey (63 off 45 balls) taking over and there was no looking back.
 



ASCO Launches Cancer.Net Mobile, a New App for iPhone, iPad, and iPod Touch

        The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing cancer physicians, released Cancer.Net Mobile for the iPhone, iPad, and iPod Touch - a free app designed by oncologists to help people with cancer and their caregivers plan and manage cancer treatment and care.



India ready for 4G by 2012, say experts

        India is all set to move on from 3G to 4G, technically known as Long Term Evolution in mobile broadband, leading industry and technology experts said at LTE India 2011 international conference organized by Bharat Exhibitions on Friday. 




Windows 8 for PCs, tablets next year

        Microsoft will ship Windows 8 for desktop computers and tablets next year and the updated Windows Phone 7 will have 500 new features.







In This Issue

Global @ Podium



 


Indian @ Podium 

  



Also @ Podium



21st -23th June, 2011
Venue:-  Shanghai, China
Details:- Click Here

23th June, 2011
Venue:-  Hyatt Regency Cambridge
Details:- Click Here

17th -29th Sept. , 2011
Venue:-  Gujarat University Hall, Ahmedabad 
Details:- Click Here

30th Nov -2nd Dec, 2011
Venue:-  Bombay Exhibition Center
Details:- Click Here









To unsubscribe:  click here

Saturday, May 14, 2011



Please Give us Your Valued Feed Back to Serve you Better
Edition#5, 15th May 2011                                                                                                    For Browser View:   Click Here

Featured Article

ZYTIGA™ (Abiraterone Acetate) Receives FDA Approval For Treatment Of Metastatic Prostate Cancer After Priority Review

      Horsham, PA (April 28, 2011) – Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ZYTIGA™ (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.

        Androgens are hormones that promote the development and maintenance of male sex characteristics. However, in prostate cancer, androgens can help fuel the tumor’s growth. Androgen production primarily occurs in the testes and adrenal glands; in men with prostate cancer, the tumor tissue is an additional source of androgens. ZYTIGA is an oral androgen biosynthesis inhibitor that works by inhibiting the CYP17 enzyme complex, which is required for the production of androgens at these three sources. 

Source :- Click here




Obama Administration Fights to Save Healthcare Law

      Lawyers for President Barack Obama go to court Tuesday to try to save the cornerstone of his healthcare overhaul, arguing that the requirement for Americans to buy insurance is constitutional.


US attacks on New Zealand drug agency draw anger

      The US Trade Representative's latest Special 301 report's criticisms of New Zealand's drug agency PHARMAC have drawn angry responses in that country.




Innovative Bed Bug Trap by SpringStar Inc. Catches Hundreds of Bed Bugs at Local Shelter

      With the ban on DDT and other powerful pesticides, bed bugs are back with a vengeance and spreading across the country. From hotels to homes and businesses, they are piggybacking on traveler’s bags, clothes and other personal belongings and end up in the strangest places: libraries; hospitals; department store changing rooms; and even movie theaters.



Harvard Medical School Faculty Advances Drug Safety Research with IBM Business Analytics

      IBM (NYSE: IBM) announced that faculty from Harvard Medical School and Brigham & Women's Hospital will use IBM business analytics technology at the core of new research that examines the effectiveness of prescription drugs and spots potential safety issues.





Argentina assures India on sorting out import restrictions on Indian pharma products 

          Argentina has assured India that it would solve the issues pertaining to restrictions on Indian pharma firms for exporting formulations and said that it would buy drugs worth 150-200 million US dollars from India in the interim.


Cipla introduces new pain free screening technology for early detection of breast cancer in India 

       
Cipla, one of the leading pharmaceutical companies from India, announces the launch of a breakthrough screening technology in India today called the ‘No Touch Breast Scan (NTBS); ' the first-ever painless, non-invasive and radiation-free breast scanning technique for detecting breast cancer at an early stage.



Sri Lanka blacklists Indian drug suppliers

       Sri Lanka's Ministry of Health has blacklisted at least a dozen of Indian drug suppliers for violating tendering procedures and supplying low quality medicines.




Jawaharlal Nehru Pharma City to see investment of Rs.25000 crore by 2017

      The Jawaharlal Nehru Pharma City (JNPC) in Visakhapatnam, a joint venture between the Hyderabad-based Ramky Group and Andhra Pradesh Industrial Infrastructure Corporation (APIIC), is expected to see a total investment of Rs.25000 crore by 2017




Hiding bin Laden: Finger of suspicion at ISI

          The finger of suspicion is now pointing squarely at the Pakistani military and intelligence for sheltering and protecting Osama bin Laden before US forces hunted him down and put a bullet in his head in the wee hours of Sunday. The coordinates of the action and sequence of events indicate that the al-Qaida fugitive may have been killed in an ISI safehouse.
 



Japan Nuclear Plant Shutdown Adds New Risk to Economy Auto Industry

        The surprise closure of another Japanese nuclear plant, this time at the power supplier to the heart of the auto industry, threatens to dampen consumer sentiment and will provide car makers with yet another reason to produce fewer cars in Japan.



Topman Announces Exclusive Sunglasses for Rock You Shades Day

        Topman is proud to announce it is producing four exclusive designs of sunglasses to help raise much needed funds and increase awareness for the Teenage Cancer Trust and the charity's Rock Your Shades day on Friday 6th May. 




Microsoft buys Skype for $8.5bn

        US software giant Microsoft will buy Internet phone service company Skype for $8.5 billion dollars, Skype is a phenomenal service that is loved by millions of people around the world," Microsoft chief executive Steve Ballmer said







In This Issue

Global @ Podium



 


Indian @ Podium 

  



Also @ Podium





     24th - 25th May, 2011
               Barcelona, Spain

21st -23th June, 2011
Venue:-  Shangai, China
Details:- Click Here


  12th - 18th May, 2011
Venue :- Dubai international  
Details:- Click Here



To unsubscribe:  click here